Search research articles
Contact Us
Filters
Showing results (31-40 of 58) with videos related to
Page
of 6
Sort By:
American Journal of Physiology. Cell Physiology
|
September 9, 2024
Dual effects of targeting neuropilin-1 in lenvatinib-resistant hepatocellular carcinoma: inhibition of tumor growth and angiogenesis
Junjie Ao, Na Qiang, Hiroaki Kanzaki, et al.
Life Sciences
|
March 15, 2005
Vitamin K2 binds 17beta-hydroxysteroid dehydrogenase 4 and modulates estrogen metabolism
Motoyuki Otsuka, Naoya Kato, Tohru Ichimura, et al.
BMC Cancer
|
April 21, 2022
Baseline soluble MICA levels act as a predictive biomarker for the efficacy of regorafenib treatment in colorectal cancer
Jun Arai, Yumi Otoyama, Ken-Ichi Fujita, et al.
Anticancer Research
|
May 6, 2021
Retinoids Decrease Soluble MICA Concentration by Inhibiting the Enzymatic Activity of ADAM9 and ADAM10
Yumi Otoyama, Jun Arai, Kaku Goto, et al.
Journal of Hepatology
|
October 20, 2006
Nucleotide change of codon 38 in the X gene of hepatitis B virus genotype C is associated with an increased risk of hepatocellular carcinoma
Ryosuke Muroyama, Naoya Kato, Haruhiko Yoshida, et al.
BMC Cancer
|
November 14, 2019
Serum fibroblast growth factor 19 serves as a potential novel biomarker for hepatocellular carcinoma
Takahiro Maeda, Hiroaki Kanzaki, Tetsuhiro Chiba, et al.
Cancers
|
May 24, 2020
A Novel Role of Interleukin 13 Receptor alpha2 in Perineural Invasion and its Association with Poor Prognosis of Patients with Pancreatic Ductal Adenocarcinoma
Toshio Fujisawa, Takeshi Shimamura, Kaku Goto, et al.
Oncology Letters
|
August 13, 2020
Interferon-γ induced PD-L1 expression and soluble PD-L1 production in gastric cancer
Yushi Imai, Tetsuhiro Chiba, Takayuki Kondo, et al.
Biochemical Pharmacology
|
February 27, 2025
MEGF6 knockdown ameliorates lenvatinib-induced muscle differentiation suppression and enhances the antitumor effect of lenvatinib on hepatocellular carcinoma
Na Qiang, Junjie Ao, Masato Nakamura, et al.
Plos One
|
October 2, 2012
Soluble MICA and a MICA variation as possible prognostic biomarkers for HBV-induced hepatocellular carcinoma
Vinod Kumar, Paulisally Hau Yi Lo, Hiromi Sawai, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 58) with videos related to
Sort By:
Page
of 6
American Journal of Physiology. Cell Physiology
|
September 9, 2024
Dual effects of targeting neuropilin-1 in lenvatinib-resistant hepatocellular carcinoma: inhibition of tumor growth and angiogenesis
Junjie Ao, Na Qiang, Hiroaki Kanzaki, et al.
Life Sciences
|
March 15, 2005
Vitamin K2 binds 17beta-hydroxysteroid dehydrogenase 4 and modulates estrogen metabolism
Motoyuki Otsuka, Naoya Kato, Tohru Ichimura, et al.
BMC Cancer
|
April 21, 2022
Baseline soluble MICA levels act as a predictive biomarker for the efficacy of regorafenib treatment in colorectal cancer
Jun Arai, Yumi Otoyama, Ken-Ichi Fujita, et al.
Anticancer Research
|
May 6, 2021
Retinoids Decrease Soluble MICA Concentration by Inhibiting the Enzymatic Activity of ADAM9 and ADAM10
Yumi Otoyama, Jun Arai, Kaku Goto, et al.
Journal of Hepatology
|
October 20, 2006
Nucleotide change of codon 38 in the X gene of hepatitis B virus genotype C is associated with an increased risk of hepatocellular carcinoma
Ryosuke Muroyama, Naoya Kato, Haruhiko Yoshida, et al.
BMC Cancer
|
November 14, 2019
Serum fibroblast growth factor 19 serves as a potential novel biomarker for hepatocellular carcinoma
Takahiro Maeda, Hiroaki Kanzaki, Tetsuhiro Chiba, et al.
Cancers
|
May 24, 2020
A Novel Role of Interleukin 13 Receptor alpha2 in Perineural Invasion and its Association with Poor Prognosis of Patients with Pancreatic Ductal Adenocarcinoma
Toshio Fujisawa, Takeshi Shimamura, Kaku Goto, et al.
Oncology Letters
|
August 13, 2020
Interferon-γ induced PD-L1 expression and soluble PD-L1 production in gastric cancer
Yushi Imai, Tetsuhiro Chiba, Takayuki Kondo, et al.
Biochemical Pharmacology
|
February 27, 2025
MEGF6 knockdown ameliorates lenvatinib-induced muscle differentiation suppression and enhances the antitumor effect of lenvatinib on hepatocellular carcinoma
Na Qiang, Junjie Ao, Masato Nakamura, et al.
Plos One
|
October 2, 2012
Soluble MICA and a MICA variation as possible prognostic biomarkers for HBV-induced hepatocellular carcinoma
Vinod Kumar, Paulisally Hau Yi Lo, Hiromi Sawai, et al.
Page
of 6